ProfileGDS4718 / 219037_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 82% 62% 80% 68% 70% 92% 91% 77% 69% 78% 83% 69% 91% 91% 91% 85% 77% 92% 89% 82% 78% 75% 78% 79% 81% 92% 76% 87% 72% 93% 90% 91% 58% 73% 91% 94% 90% 80% 75% 82% 75% 91% 86% 91% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.0427682
GSM549102patient 115, normal, homogenized [OPG study]6.2745462
GSM549104patient 119, normal, homogenized [OPG study]7.9384780
GSM549108patient 138, normal, homogenized [OPG study]6.6977868
GSM549119patient 077, normal, homogenized [OPG study]6.8479770
GSM549133patient 032, cancer, homogenized [OPG study]9.7041192
GSM549139patient 042, cancer, homogenized [OPG study]9.3975991
GSM549099patient 107, normal, homogenized [OPG study]7.5004977
GSM549109patient 139, normal, homogenized [OPG study]6.7648469
GSM549110patient 046, normal, homogenized [OPG study]7.6250178
GSM549114patient 063, normal, homogenized [OPG study]8.3397583
GSM549122patient 082, normal, homogenized [OPG study]6.8404169
GSM549134patient 033, cancer, homogenized [OPG study]9.294891
GSM549136patient 036, cancer, homogenized [OPG study]9.4125591
GSM549140patient 044, cancer, homogenized [OPG study]9.3612391
GSM549111patient 047, normal, homogenized [OPG study]8.4891785
GSM549113patient 057, normal, homogenized [OPG study]7.6106377
GSM549132patient 031, cancer, homogenized [OPG study]9.4568192
GSM549137patient 038, cancer, homogenized [OPG study]8.9834689
GSM549142patient 047, cancer, homogenized [OPG study]7.8098282
GSM549100patient 110, normal, homogenized [OPG study]7.549578
GSM549107patient 135, normal, homogenized [OPG study]7.3664775
GSM549115patient 068, normal, homogenized [OPG study]7.7163878
GSM549116patient 072, normal, homogenized [OPG study]7.8475179
GSM549120patient 078, normal, homogenized [OPG study]8.0321381
GSM549131patient 030, cancer, homogenized [OPG study]9.6398692
GSM549118patient 074, normal, homogenized [OPG study]7.4278676
GSM549129patient 027, cancer, homogenized [OPG study]8.6541387
GSM549123patient 088, normal, homogenized [OPG study]7.0584172
GSM549124patient 006, cancer, homogenized [OPG study]9.6698893
GSM549126patient 015, cancer, homogenized [OPG study]9.2081290
GSM549128patient 025, cancer, homogenized [OPG study]9.3702191
GSM549103patient 117, normal, homogenized [OPG study]6.0015258
GSM549117patient 073, normal, homogenized [OPG study]7.1066673
GSM549138patient 041, cancer, homogenized [OPG study]9.3402291
GSM549141patient 045, cancer, homogenized [OPG study]9.9284594
GSM549130patient 028, cancer, homogenized [OPG study]9.0912890
GSM549101patient 111, normal, homogenized [OPG study]7.8280380
GSM549105patient 128, normal, homogenized [OPG study]7.3041875
GSM549106patient 134, normal, homogenized [OPG study]8.2028582
GSM549112patient 048, normal, homogenized [OPG study]7.3509875
GSM549125patient 011, cancer, homogenized [OPG study]9.314391
GSM549127patient 024, cancer, homogenized [OPG study]8.600286
GSM549135patient 035, cancer, homogenized [OPG study]9.4770191